News | January 29, 2024
Jubilant Pharmova Singapore to sell its entire 25.8% stake in Sofie Biosciences, USA
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
JPL plans to sell its entire 25.8% equity stake in Sofie for aggregate proceeds of about US$ 139.43 million
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
AMI to become part of Enpro’s Sealing Technologies Segment
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
These regulatory approvals signify a significant milestone for Venus Remedies Limited
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Subscribe To Our Newsletter & Stay Updated
